REVIEW: tau protein pathology in Alzheimer’s disease and related disorders
Tóm tắt
Abundant neurofibrillary lesions made of hyperphosphorylated microtubule‐associated protein tau constitute one of the defining neuropathological features of Alzheimer’s disease. However, tau containing filamentous inclusions in neurones and/or glial cells also define a number of other neurodegenerative disorders clinically characterized by dementia and/or motor syndromes. All these disorders, therefore, are grouped under the generic term of tauopathies. In the first part of this review we outline the morphological and biochemical features of some major tauopathies, e.g. Alzheimer’s disease, argyrophilic grain disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. The impact of the recent finding of tau gene mutations in familial frontotemporal dementia and parkinsonism linked to chromosome 17 on other tauopathies is discussed in the second part. The review closes with a look towards a new understanding of neurodegenerative disorders characterized by filamentous nerve cell inclusions. The recent identification of the major protein component of their respective inclusions led to a surprising convergence of seemingly unrelated disorders. The new findings now allow us to classify neurodegenerative disorders with filamentous nerve cell inclusions into four main categories: (i) the tauopathies; (ii) the α‐synucleinopathies; (iii) the polyglutamine disorders; and (iv) the iquitin disorders’. Within the proposed classification scheme, tauopathies constitute the most frequent type of disorder.
Từ khóa
Tài liệu tham khảo
Askanas V, 1994, Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau., Am J Pathol, 144, 177
Auer IA, 1995, Paired helical filament tau in Niemann‐Pick disease type C is similar to PHF‐tau in Alzheimer’s disease., Acta Neuropathol, 90, 547, 10.1007/BF00318566
Braak E, 1994, A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads., Acta Neuropathol, 87, 554, 10.1007/BF00293315
Buée‐Scherrer V, 1995, Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism‐dementia complex of Guam: immunochemical characterization of tau proteins., Am J Pathol, 146, 924
Feany MB, 1995, Widespread cytoskeletal pathology characterizes corticobasal degeneration., Am J Pathol, 146, 1388
Gallyas F, 1971, Silver staining of Alzheimer’s neurofibrillary changes by means of physical development., Acta Morph Acad Sci Hung, 19, 1
GoedertM TrojanowskiJQ LeeVM‐YThe neurofibrillary pathology of Alzheimer’s disease. InThe Molecular and Genetic Basis of Neurological Diseases.Rosenberg RN Prusiner SB DiMauro S Barchi RL eds. Boston: Butterworth‐Heinemann 1997;61327
Greenberg SG, 1992, Hydrofluoric acid‐treated tau PHF proteins display the same biochemical properties as normal tau., J Biol Chem, 267, 564, 10.1016/S0021-9258(18)48531-6
Hasegawa M, 1992, Protein sequence and mass spectrometric analyses of tau in the Alzheimer’s disease brain., J Biol Chem, 267, 7047, 10.1016/S0021-9258(18)41890-X
Ksiezak‐Reding H, 1994, Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration., Am J Pathol, 149, 639
Probst A, 1993, Pathology of the striatum in progressive supranuclear palsy: abnormal tau proteins in astrocytes and cholinergic interneurons., Neurodegeneration, 2, 183
Tolnay M, 1999, Low amyloid (Aβ) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer’s disease Neuropath Appl Neurobiol, 25
Tolnay M, 1999, Widespread tau pathology in hereditary frontotemporal dementia and parkinsonism: family SOT 254 (abstract)., Neuropathol Appl Neurobiol, 25, 146